Skip Nav Destination
Issues
1 February 2016
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 0149-5992
EISSN 1935-5548
In this Issue
In This Issue
In This Issue of Diabetes Care
Diabetes Care January 2016, Vol.39, 177-178. doi:https://doi.org/10.2337/dc16-ti02
Perspectives in Care
The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell–Centric Classification Schema
Stanley S. Schwartz; Solomon Epstein; Barbara E. Corkey; Struan F.A. Grant; James R. Gavin, III; Richard B. Aguilar
Diabetes Care January 2016, Vol.39, 179-186. doi:https://doi.org/10.2337/dc15-1585
Commentary
Mechanism of Metformin: A Tale of Two Sites
Diabetes Care January 2016, Vol.39, 187-189. doi:https://doi.org/10.2337/dci15-0013
Clinical Care / Education / Nutrition / Psychosocial Research
Health Care Transition in Young Adults With Type 1 Diabetes: Perspectives of Adult Endocrinologists in the U.S.
Katharine C. Garvey; Gabriela H. Telo; Joseph S. Needleman; Peter Forbes; Jonathan A. Finkelstein; Lori M. Laffel
Diabetes Care December 2015, Vol.39, 190-197. doi:https://doi.org/10.2337/dc15-1775
The Primary Glucose-Lowering Effect of Metformin Resides in the Gut, Not the Circulation: Results From Short-term Pharmacokinetic and 12-Week Dose-Ranging Studies
John B. Buse; Ralph A. DeFronzo; Julio Rosenstock; Terri Kim; Colleen Burns; Sharon Skare; Alain Baron; Mark Fineman
Diabetes Care August 2015, Vol.39, 198-205. doi:https://doi.org/10.2337/dc15-0488
Safety and Efficacy of Liraglutide in Patients With Type 2 Diabetes and End-Stage Renal Disease: An Investigator-Initiated, Placebo-Controlled, Double-Blind, Parallel-Group, Randomized Trial
Thomas Idorn; Filip K. Knop; Morten B. Jørgensen; Tonny Jensen; Marsela Resuli; Pernille M. Hansen; Karl B. Christensen; Jens J. Holst; Mads Hornum; Bo Feldt-Rasmussen
Diabetes Care August 2015, Vol.39, 206-213. doi:https://doi.org/10.2337/dc15-1025
Liraglutide Reduces CNS Activation in Response to Visual Food Cues Only After Short-term Treatment in Patients With Type 2 Diabetes
Jennifer S. ten Kulve; Dick J. Veltman; Liselotte van Bloemendaal; Frederik Barkhof; Madeleine L. Drent; Michaela Diamant; Richard G. IJzerman
Diabetes Care August 2015, Vol.39, 214-221. doi:https://doi.org/10.2337/dc15-0772
Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial
Melanie J. Davies; Stephen C. Bain; Stephen L. Atkin; Peter Rossing; David Scott; Minara S. Shamkhalova; Heidrun Bosch-Traberg; Annika Syrén; Guillermo E. Umpierrez
Diabetes Care December 2015, Vol.39, 222-230. doi:https://doi.org/10.2337/dc14-2883
A Phase 2, Randomized, Dose-Finding Study of the Novel Once-Weekly Human GLP-1 Analog, Semaglutide, Compared With Placebo and Open-Label Liraglutide in Patients With Type 2 Diabetes
Michael A. Nauck; for the Study 1821 Investigators; John R. Petrie; for the Study 1821 Investigators; Giorgio Sesti; for the Study 1821 Investigators; Edoardo Mannucci; for the Study 1821 Investigators; Jean-Pierre Courrèges; for the Study 1821 Investigators; Marie L. Lindegaard; for the Study 1821 Investigators; Christine B. Jensen; for the Study 1821 Investigators; Stephen L. Atkin; for the Study 1821 Investigators
Diabetes Care September 2015, Vol.39, 231-241. doi:https://doi.org/10.2337/dc15-0165
Effect of the GLP-1 Receptor Agonist Lixisenatide on Counterregulatory Responses to Hypoglycemia in Subjects With Insulin-Treated Type 2 Diabetes
Diabetes Care November 2015, Vol.39, 242-249. doi:https://doi.org/10.2337/dc15-1274
Markers of β-Cell Failure Predict Poor Glycemic Response to GLP-1 Receptor Agonist Therapy in Type 2 Diabetes
Angus G. Jones; for the PRIBA Study Group; Timothy J. McDonald; for the PRIBA Study Group; Beverley M. Shields; for the PRIBA Study Group; Anita V. Hill; for the PRIBA Study Group; Christopher J. Hyde; for the PRIBA Study Group; Bridget A. Knight; for the PRIBA Study Group; Andrew T. Hattersley; for the PRIBA Study Group
Diabetes Care August 2015, Vol.39, 250-257. doi:https://doi.org/10.2337/dc15-0258
Epidemiology / Health Services Research
Adherence to Oral Glucose-Lowering Therapies and Associations With 1-Year HbA1c: A Retrospective Cohort Analysis in a Large Primary Care Database
Andrew J. Farmer; for the MASTERMIND Consortium; Lauren R. Rodgers; for the MASTERMIND Consortium; Mike Lonergan; for the MASTERMIND Consortium; Beverley Shields; for the MASTERMIND Consortium; Michael N. Weedon; for the MASTERMIND Consortium; Louise Donnelly; for the MASTERMIND Consortium; Rury R. Holman; for the MASTERMIND Consortium; Ewan R. Pearson; for the MASTERMIND Consortium; Andrew T. Hattersley; for the MASTERMIND Consortium
Diabetes Care December 2015, Vol.39, 258-263. doi:https://doi.org/10.2337/dc15-1194
Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study
Michael R. Rickels; for the T1D Exchange Intranasal Glucagon Investigators; Katrina J. Ruedy; for the T1D Exchange Intranasal Glucagon Investigators; Nicole C. Foster; for the T1D Exchange Intranasal Glucagon Investigators; Claude A. Piché; for the T1D Exchange Intranasal Glucagon Investigators; Hélène Dulude; for the T1D Exchange Intranasal Glucagon Investigators; Jennifer L. Sherr; for the T1D Exchange Intranasal Glucagon Investigators; William V. Tamborlane; for the T1D Exchange Intranasal Glucagon Investigators; Kathleen E. Bethin; for the T1D Exchange Intranasal Glucagon Investigators; Linda A. DiMeglio; for the T1D Exchange Intranasal Glucagon Investigators; R. Paul Wadwa; for the T1D Exchange Intranasal Glucagon Investigators; Andrew J. Ahmann; for the T1D Exchange Intranasal Glucagon Investigators; Michael J. Haller; for the T1D Exchange Intranasal Glucagon Investigators; Brandon M. Nathan; for the T1D Exchange Intranasal Glucagon Investigators; Santica M. Marcovina; for the T1D Exchange Intranasal Glucagon Investigators; Emmanouil Rampakakis; for the T1D Exchange Intranasal Glucagon Investigators; Linyan Meng; for the T1D Exchange Intranasal Glucagon Investigators; Roy W. Beck; for the T1D Exchange Intranasal Glucagon Investigators
Diabetes Care December 2015, Vol.39, 264-270. doi:https://doi.org/10.2337/dc15-1498
A1C Combined With Glycated Albumin Improves Detection of Prediabetes in Africans: The Africans in America Study
Anne E. Sumner; Michelle T. Duong; Paola C. Aldana; Madia Ricks; Marshall K. Tulloch-Reid; Jay N. Lozier; Stephanie T. Chung; David B. Sacks
Diabetes Care December 2015, Vol.39, 271-277. doi:https://doi.org/10.2337/dc15-1699
Prevalence of Diabetes and Diabetic Nephropathy in a Large U.S. Commercially Insured Pediatric Population, 2002–2013
Diabetes Care December 2015, Vol.39, 278-284. doi:https://doi.org/10.2337/dc15-1710
Racial Differences in the Performance of Existing Risk Prediction Models for Incident Type 2 Diabetes: The CARDIA Study
Mary E. Lacy; Gregory A. Wellenius; Mercedes R. Carnethon; Eric B. Loucks; April P. Carson; Xi Luo; Catarina I. Kiefe; Annie Gjelsvik; Erica P. Gunderson; Charles B. Eaton; Wen-Chih Wu
Diabetes Care January 2016, Vol.39, 285-291. doi:https://doi.org/10.2337/dc15-0509
Pathophysiology / Complications
Effect of Bariatric Surgery on Adipose Tissue Glucose Metabolism in Different Depots in Patients With or Without Type 2 Diabetes
Prince Dadson; Linda Landini; Mika Helmiö; Jarna C. Hannukainen; Heidi Immonen; Miikka-Juhani Honka; Marco Bucci; Nina Savisto; Minna Soinio; Paulina Salminen; Riitta Parkkola; Jussi Pihlajamäki; Patricia Iozzo; Ele Ferrannini; Pirjo Nuutila
Diabetes Care December 2015, Vol.39, 292-299. doi:https://doi.org/10.2337/dc15-1447
Meta-analysis
Type 2 Diabetes as a Risk Factor for Dementia in Women Compared With Men: A Pooled Analysis of 2.3 Million People Comprising More Than 100,000 Cases of Dementia
Saion Chatterjee; Sanne A.E. Peters; Mark Woodward; Silvia Mejia Arango; G. David Batty; Nigel Beckett; Alexa Beiser; Amy R. Borenstein; Paul K. Crane; Mary Haan; Linda B. Hassing; Kathleen M. Hayden; Yutaka Kiyohara; Eric B. Larson; Chung-Yi Li; Toshiharu Ninomiya; Tomoyuki Ohara; Ruth Peters; Tom C. Russ; Sudha Seshadri; Bjørn H. Strand; Rod Walker; Weili Xu; Rachel R. Huxley
Diabetes Care December 2015, Vol.39, 300-307. doi:https://doi.org/10.2337/dc15-1588
Position Statement
Management of Diabetes in Long-term Care and Skilled Nursing Facilities: A Position Statement of the American Diabetes Association
Medha N. Munshi; Hermes Florez; Elbert S. Huang; Rita R. Kalyani; Maria Mupanomunda; Naushira Pandya; Carrie S. Swift; Tracey H. Taveira; Linda B. Haas
Diabetes Care January 2016, Vol.39, 308-318. doi:https://doi.org/10.2337/dc15-2512
Statement of Retraction
Statement of Retraction. Nuts as a Replacement for Carbohydrates in the Diabetic Diet. Diabetes Care 2011;34:1706–1711. DOI: 10.2337/dc11-0338
David J.A. Jenkins; Cyril W.C. Kendall; Monica S. Banach; Korbua Srichaikul; Edward Vidgen; Sandy Mitchell; Tina Parker; Stephanie Nishi; Balachandran Bashyam; Russell de Souza; Christopher Ireland; Robert G. Josse
Diabetes Care January 2016, Vol.39, 319. doi:https://doi.org/10.2337/dc16-rt02
Issues and Events
E-Letters: Observations
Could the Discrepancy in Perceived Emotional Care Received and Provided Be a Barrier to Active Diabetes Self-management? Insights From the Second Diabetes Attitudes, Wishes and Needs (DAWN2) Study
Katharine D. Barnard; Richard I.G. Holt; Pamela A. Dyson; Michael H. Cummings; Naresh Kanumilli; Simon O’Neill; Gwen Hall
Diabetes Care January 2016, Vol.39, e20-e21. doi:https://doi.org/10.2337/dc15-0674
Effects of GLP-1 Receptor Agonists on Heart Rate and the Autonomic Nervous System Using Holter Electrocardiography and Power Spectrum Analysis of Heart Rate Variability
Yuki Nakatani; Atsuhiko Kawabe; Mihoko Matsumura; Yoshimasa Aso; Takanori Yasu; Nobuyuki Banba; Takaaki Nakamoto
Diabetes Care December 2015, Vol.39, e22-e23. doi:https://doi.org/10.2337/dc15-1437
E-Letters: Comments and Responses
Response to Comment on Nunley et al. Clinically Relevant Cognitive Impairment in Middle-Aged Adults With Childhood-Onset Type 1 Diabetes. Diabetes Care 2015;38:1768–1776
Karen A. Nunley; Christopher M. Ryan; Judith A. Saxton; Tina Costacou; Trevor J. Orchard; Caterina Rosano
Diabetes Care January 2016, Vol.39, e25. doi:https://doi.org/10.2337/dci15-0028
Comment on Hoffstad et al. Diabetes, Lower-Extremity Amputation, and Death. Diabetes Care 2015;38:1852–1857
Diabetes Care January 2016, Vol.39, e26. doi:https://doi.org/10.2337/dc15-1972
Response to Comment on Hoffstad et al. Diabetes, Lower-Extremity Amputation, and Death. Diabetes Care 2015;38:1852–1857
Diabetes Care January 2016, Vol.39, e27. doi:https://doi.org/10.2337/dci15-0025
Comment on Jakubowicz et al. Fasting Until Noon Triggers Increased Postprandial Hyperglycemia and Impaired Insulin Response After Lunch and Dinner in Individuals With Type 2 Diabetes: A Randomized Clinical Trial. Diabetes Care 2015;38:1820–1826
Diabetes Care January 2016, Vol.39, e28. doi:https://doi.org/10.2337/dc15-2362
